Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in Locally Advanced Resectable Rectal Cancer: A Randomized, Non-Comparative Phase II Study
Conditions
Interventions
Bevacizumab
Oxaliplatin
+4 more
Locations
40
France
ICO Paul Papin; Oncologie Medicale.
Angers, France
Angers, France
HOPITAL JEAN MINJOZ; Oncologie
Besançon, France
Besançon, France
Hopital Saint Andre; Département de Radiothérapie Et D'Oncologie Médicale
Bordeaux, France
Bordeaux, France
Start Date
October 23, 2007
Primary Completion Date
March 23, 2016
Completion Date
March 23, 2016
Last Updated
August 4, 2017
NCT06696768
NCT04704661
NCT04929028
NCT05489211
NCT06625775
NCT04674267
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions